Data from A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy

Authors:
  • JSJiangdian Song
    Jiangdian Song
  • JSJingyun Shi
    Jingyun Shi
  • DDDi Dong
    Di Dong
  • MFMengjie Fang
    Mengjie Fang
  • WZWenzhao Zhong
    Wenzhao Zhong
  • KWKun Wang
    Kun Wang
  • NWNing Wu
    Ning Wu
  • YHYanqi Huang
    Yanqi Huang
  • ZLZhenyu Liu
    Zhenyu Liu
  • YCYue Cheng
    Yue Cheng
  • YGYuncui Gan
    Yuncui Gan
  • YZYongzhao Zhou
    Yongzhao Zhou
Open Access
Publisher website
Google Scholar
Abstract
The data disclosed in this study.